This disease is characterized by stunted growth, failure to thrive, facial dysmorphia, corneal clouding, organomegaly, heart disease, and joint disease.
Mansour TA, Woolard KD, Vernau KL, Ancona DM, Thomasy SM, Sebbag L, Moore BA, Knipe MF, Seada HA, Cowan TM, Aguilar M, Titus Brown C, Bannasch DL. Whole genome sequencing for mutation discovery in a single case of lysosomal storage disease (MPS type 1) in the dog. Sci Rep. 2020 Apr 16;10(1):6558. doi: 10.1038/s41598-020-63451-4. PMID: 32300136; PMCID: PMC7162951.
Menon KP, Tieu PT, Neufeld EF. Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I. Genomics. 1992 Nov;14(3):763-8. doi: 10.1016/s0888-7543(05)80182-x. PMID: 1339393.
Shull RM, Helman RG, Spellacy E, Constantopoulos G, Munger RJ, Neufeld EF. Morphologic and biochemical studies of canine mucopolysaccharidosis I. Am J Pathol. 1984 Mar;114(3):487-95. PMID: 6320652; PMCID: PMC1900418.
Spellacy E, Shull RM, Constantopoulos G, Neufeld EF. A canine model of human alpha-L-iduronidase deficiency. Proc Natl Acad Sci U S A. 1983 Oct;80(19):6091-5. doi: 10.1073/pnas.80.19.6091. PMID: 6412235; PMCID: PMC534366.
Shull RM, Munger RJ, Spellacy E, Hall CW, Constantopoulos G, Neufeld EF. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I. Am J Pathol. 1982 Nov;109(2):244-8. PMID: 6215865; PMCID: PMC1916101.
He X, Li CM, Simonaro CM, Wan Q, Haskins ME, Desnick RJ, Schuchman EH. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats. Mol Genet Metab. 1999 Jun;67(2):106-12. doi: 10.1006/mgme.1999.2860. PMID: 10356309.